EUVIMEDEUVIMED entdecken
Vergleichsstudie

Comparative analysis of charge heterogeneity in anti-sclerostin monoclonal antibodies produced via continuous perfusion and fed-batch processes

Yu Yi, Dawei Xie, Xichen Zhang, Jianfeng Mei, Yanlu Zhang, Jianshu Chen, Guoqing Ying

Protein Expression and Purification · 2026-09 · 242 · 106958

DOI: 10.1016/j.pep.2026.106958 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Protein Expression and Purification, 2026-09. Verfasst von Yu Yi und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, 310014, China. Electronic address: yiyu1106@zjut.edu.cn. Hauptthemen laut MEDLINE: Antibodies, Monoclonal. Die Arbeit nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As critical quality attributes, post-translational modifications (PTMs) of therapeutic monoclonal antibodies in production impact their structural stability, charge heterogeneity, and clinical efficacy. This study elucidated PTM-driven charge isomer disparities in anti-sclerostin monoclonal antibodies from continuous perfusion versus fed-batch bioreactor processes. By developing an integrated analytical platform combining strong cation-exchange chromatography, size-exclusion chromatography, and non-reducing capillary electrophoresis with high-resolution mass spectrometry, we precisely characterized molecular weight variations and signature PTM profiles across distinct charge isomers. The study revealed that basic isomer 1 predominantly originated from C-terminal glycine loss and methionine oxidation, while basic isomer 2 arose from incomplete N-terminal glutamine cyclization and N-terminal truncation. The fed-batch process uniquely induced degradation at the heavy chain Met250-Ile251 site and significantly elevated low-molecular-weight species content. Crucially, antibodies from both processes exhibited minimal differences in purity and PTM profiles, robustly validating the feasibility of process transition. Biological activity assessment results showed that the relative binding activities of charge isomers from both processes ranged between 90 and 121%. The equilibrium dissociation constant values for binding to the neonatal fragment crystallizable receptor were all within (5∼9) × 10-1 μM, indicating that FcRn function was unaffected by charge heterogeneity or the process. In summary, this study systematically compares the impact of two production processes-fed-batch and continuous perfusion-on the charge heterogeneity and biological activity of an anti-sclerostin monoclonal antibody. This work not only identifies key quality benchmarks for antibody process optimization but also establishes a PTM fingerprint-based standard for evaluating process comparability, providing critical guidance for advancing continuous biomanufacturing technologies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, MonoclonalAnimalsBioreactorsProtein Processing, Post-TranslationalHumansCHO CellsCricetulusPerfusion

Stichwörter der Autor:innen

Anti-sclerostin monoclonal antibodyCharge isomersContinuous perfusionFed-batchProcess changes

Substanzen

Antibodies, Monoclonal

Autor:innen und Institutionen

  • College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, 310014, China. Electronic address: yiyu1106@zjut.edu.cn.
  • College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, 310014, China. Electronic address: 221122070110@zjut.edu.cn.
  • HJB(Hangzhou) Co.,Ltd, Building 3, Hangzhou Pharmaceutical Town, No.291 Fucheng Road, Hangzhou, Zhejiang, China. Electronic address: Xichen.Zhang@hjbbio.com.
  • College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, 310014, China. Electronic address: mrion@zjut.edu.cn.
  • College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, 310014, China. Electronic address: zhyanlu@gmail.com.
  • College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, 310014, China. Electronic address: chen-jianshu@126.com.

Zitieren

APA

Yi, Y., Xie, D., Zhang, X., Mei, J., Zhang, Y., Chen, J., & Ying, G. (2026). Comparative analysis of charge heterogeneity in anti-sclerostin monoclonal antibodies produced via continuous perfusion and fed-batch processes. Protein Expression and Purification, 242, 106958. https://doi.org/10.1016/j.pep.2026.106958

Vancouver

Yi Y, Xie D, Zhang X, Mei J, Zhang Y, Chen J, et al. Comparative analysis of charge heterogeneity in anti-sclerostin monoclonal antibodies produced via continuous perfusion and fed-batch processes. Protein Expression and Purification. 2026;242:106958. doi:10.1016/j.pep.2026.106958

BibTeX
@article{Yi2026,
  author = {Yi, Yu and Xie, Dawei and Zhang, Xichen and Mei, Jianfeng and Zhang, Yanlu and Chen, Jianshu and Ying, Guoqing},
  title = {Comparative analysis of charge heterogeneity in anti-sclerostin monoclonal antibodies produced via continuous perfusion and fed-batch processes},
  journal = {Protein Expression and Purification},
  year = {2026},
  volume = {242},
  pages = {106958},
  doi = {10.1016/j.pep.2026.106958}
}
Kostenlos starten →